いびき防止装置・いびき手術のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2024年)

【英語タイトル】Europe Anti-Snoring Devices and Snoring Surgery Market Analysis : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Data Bridge Market Researchが出版した調査資料(DBMR810026)・商品コード:DBMR810026
・発行会社(調査会社):Data Bridge Market Research
・発行日:2017年12月
・ページ数:248
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:ヨーロッパ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD4,200 ⇒換算¥546,000見積依頼/購入/質問フォーム
Corporate UserUSD5,400 ⇒換算¥702,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、いびき防止装置・いびき手術のヨーロッパ市場について調査・分析し、いびき防止装置・いびき手術のヨーロッパ市場動向、市場予測、セグメント別分析、いびき防止装置・いびき手術市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

The Europe Anti-snoring devices and snoring surgery Market is accounted to reach USD 5,261.19 million by 2024 from USD 2,760.94 million in 2016, at a CAGR of 8.5%
The major factors driving the growth of this market are the rise in the geriatric as well as obese population, more of technological advancement, growing awareness regarding ill effects of snoring and related advantages, increase in the consumption of cigarettes and alcohol are furthermore boosting the growth of the global anti-snoring devices and snoring surgery market. On the other hand, unfavourable reimbursement policies, and high cost of surgeries and custom-made oral devices may hinder the growth of the market. The anti-snoring devices and snoring surgery market in the Europe region is leading in France.

The key market players for Europe Anti-snoring devices and snoring surgery Market are listed below:
• GE Healthcare,
• Medtronic a
• Koninklijke
• Philips N.V.

The market is further segmented into:
• hospitals,
• home healthcare,
• sleep clinics,
• community healthcare
• others

The Europe anti-snoring devices and snoring surgery market is segmented on the basis of product type, end user and distribution channel. Based on type, the Europe anti-snoring devices and snoring surgery market is segmented on the basis of product type into six oral appliances/mouthpieces, nasal devices, EPAP (Expiratory Positive Airway Pressure) therapy devices, continuous positive airway pressure (CPAP) devices, position control devices, chin straps. In 2017, oral appliances/mouthpieces segment is expected to dominate the Europe anti-snoring devices and snoring surgery market with 45.8% market share and is expected to reach USD 2405.72 million by 2024, with a CAGR of 8.5% in the forecast period 2017 to 2024. However, nasal devices segment is expected to grow at the highest CAGR of 9.7% in the forecast period, and is expected to reach USD 1631.54 million in 2024 from USD 784.25 million in 2016.
The Europe anti-snoring devices and snoring surgery market is segmented based on type into six notable segments; Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), Radiofrequency Ablation (somnoplasty), Pillar Procedure, Palatal Stiffening Procedures, Injection Snoreplasty/Sclerotherapy and Others. In 2017, Uvulopalatopharyngoplasty (UPPP) segment is expected to dominate the Europe anti-snoring devices and snoring surgery devices and snoring surgery market with 31.6% market share and is expected to reach USD 1,779.52 million by 2024, with a CAGR of 8.5% in the forecast period 2017 to 2024. However, Radiofrequency Ablation (somnoplasty) segment is expected to grow with the highest CAGR of 10.0% in the forecast period, and is expected to reach USD 1,204.17 million in 2024 from USD 566.76 million in 2016.
On the basis of end user, the Europe anti-snoring devices and snoring surgery market is segmented into five notable segments; hospitals, home healthcare, sleep clinics, community healthcare and others. In 2017, hospitals segment is expected to dominate the Europe anti-snoring devices and snoring surgery market with 62.4% market share and is expected to reach USD 3167.01 million by 2024, with a CAGR of 8.0% in the forecast period 2017 to 2024. However, home healthcare segment is expected to grow at the highest CAGR of 9.9% in the forecast period, and is expected to reach USD 1335.89 million in 2024 from USD 635.23 million in 2016.
On the basis of distribution channel, the Europe anti-snoring devices and snoring surgery market is classified into retail and direct sales. In 2017, retail segment is expected to dominate the Europe anti-snoring devices and snoring surgery market with 78.5% market share and is expected to reach USD 4243.01 million by 2024, with the highest CAGR of 9.0% in the forecast period 2017 to 2024.
Based on geography, the Europe Anti-snoring devices and snoring surgery market is segmented into geographical regions, such as
• Germany,
• United Kingdom,
• France,
• Spain,
• Italy,
• Russia,
• Turkey,
• Belgium,
• Nether lands,
• Switzerland,
• Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe Anti-snoring devices and snoring surgery Market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

TABLE OF CONTENTS

1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET 24
1.4. CURRENCY AND PRICING 25
1.5. LIMITATION 25
1.6. MARKETS COVERED 26
2. MARKET SEGMENTATION 28
2.1. MARKETS COVERED 28
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 30
2.4. CURRENCY AND PRICING 30
2.5. RESEARCH METHODOLOGY 31
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7. SECONDARY SOURCES 35
2.8. ASSUMPTIONS 35
3. MARKET OVERVIEW 36
3.1. DRIVERS 38


3.2. RESTRAINTS 40

3.3. OPPORTUNITIES 41
3.4. CHALLENGES 42
4. EXECUTIVE SUMMARY 43
5. PREMIUM INSIGHTS 46
6. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY PRODUCT TYPE 49
6.1. OVERVIEW 59
6.2. ORAL APPLIANCES/MOUTHPIECES 61
6.2.1. MANDIBULAR ADVANCEMENT DEVICES (MADS) 63
6.2.1.1. NON-CUSTOM MADS 63
6.2.1.2. CUSTOM-MADE MADS 63
6.2.2. TONGUE-RETAINING DEVICES (TRDS) 63
6.3. NASAL DEVICES 64
6.3.1. EXTERNAL NASAL DILATORS 65
6.3.2. OTHER NASAL DEVICES 65
6.3.2.1. NASAL STENTS 66
6.3.2.2. NASAL CLIPS 66
6.3.2.3. SEPTAL STIMULATORS 67
6.3.2.4. NASAL CONES 67
6.3.2.5. OTHERS 67
6.4. POSITION CONTROL DEVICES 68
6.5. CHIN STRAPS 69
6.6. EPAP THERAPY DEVICES 70
6.7. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES 71

7. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY END-USER 72
7.1. OVERVIEW 73
7.2. HOSPITALS 75
7.3. COMMUNITY HEALTHCARE 76
7.4. SLEEP CLINICS 77
7.5. HOME HEALTHCARE 78
7.6. OTHERS 79
8. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY TYPE 80
8.1. OVERVIEW 81
8.2. UVULOPALATOPHARYNGOPLASTY (UPPP) 82
8.3. LASER-ASSISTED UVULOPALATOPLASTY (LAUP) 83
8.4. RADIO FREQUENCY ABLATION (SOMNOPLASTY) 84
8.5. PILLAR PROCEDURE 85
8.6. PALATAL STIFFENING PROCEDURES 86
8.7. INJECTION SNOREPLASTY/SCLEROTHERAPY 87
8.8. OTHER ANTI-SNORING SURGICAL PROCEDURES 88
9. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY DISTRIBUTION CHANNEL 89
9.1. OVERVIEW 90
9.2. RETAIL 92
9.3. DIRECT SALES 93
10. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY GEOGRAPHY 101
10.1. OVERVIEW 102
10.2. EUROPE 107
10.2.1. GERMANY 117
10.2.2. FRANCE 120
10.2.3. U.K. 123
10.2.4. ITALY 126
10.2.5. SPAIN 129
10.2.6. RUSSIA 132
10.2.7. TURKEY 135
10.2.8. BELGIUM 1310
10.2.9. NETHERLANDS 141
10.2.10. SWITZERLAND 144
10.2.11. REST OF EUROPE 147
11. COMPANY LANDSCAPE 221
11.2. COMPANY SHARE ANALYSIS: EUROPE 222
12 COMPANY PROFILE. 226
12.1. SLEEPING WELL, LLC 293
12.1.1. COMPANY OVERVIEW 293
12.1.2. COMPANY SNAPSHOT 293
12.1.3. PRODUCT PORTFOLIO 293
12.1.4. RECENT DEVELOPMENTS 294
12.2. APNEA SCIENCES CORPORATION 294
12.2.1. COMPANY OVERVIEW 294
12.2.2. COMPANY SNAPSHOT 294
12.2.3. PRODUCT PORTFOLIO 294
12.2.4. RECENT DEVELOPMENTS 295
12.3. THE PURE SLEEP COMPANY 296
12.3.1. COMPANY OVERVIEW 296
12.3.2. COMPANY SNAPSHOT 296
12.3.3. PRODUCT PORTFOLIO 296
12.3.4. RECENT DEVELOPMENTS 296
12.4. KONINKLIJKE PHILIPS N.V. 297
12.4.1. COMPANY OVERVIEW 297
12.4.2. REVENUE ANALYSIS 297
12.4.3. PRODUCT PORTFOLIO 298
12.4.4. RECENT DEVELOPMENTS 299
12.5. SOMNOMED 300
12.5.1. COMPANY OVERVIEW 300
12.5.2. REVENUE ANALYSIS 300
12.5.3. PRODUCT PORTFOLIO 301
12.5.4. RECENT DEVELOPMENTS 301
12.6. FISHER AND PAYKEL HEALTHCARE LIMITED. 302
12.6.1. COMPANY OVERVIEW 302
12.6.2. REVENUE ANALYSIS 302
12.6.3. PRODUCT PORTFOLIO 303
12.6.4. RECENT DEVELOPMENTS 304
12.7. RESMED 305
12.7.1. COMPANY OVERVIEW 305
12.7.2. REVENUE ANALYSIS 305
12.7.3. PRODUCT PORTFOLIO 306
12.7.4. RECENT DEVELOPMENTS 307
12.8. AIRWAY MANAGEMENT INC. 308
12.8.1. COMPANY OVERVIEW 308
12.8.2. COMPANY SNAPSHOT 308
12.8.3. PRODUCT PORTFOLIO 308
12.8.4. RECENT DEVELOPMENTS 308
12.9. THERAVENT, INC. 309
12.9.1. COMPANY OVERVIEW 309
12.9.2. COMPANY SNAPSHOT 309
12.9.3. PRODUCT PORTFOLIO 309
12.9.4. RECENT DEVELOPMENTS 309

12.10. TOMED GMBH 310
12.10.1. COMPANY OVERVIEW 310
12.10.2. REVENUE ANALYSIS 310
12.10.3. PRODUCT PORTFOLIO 310
12.10.4. RECENT DEVELOPMENTS 310
12.11. GLAXOSMITHKLINE PLC. 311
12.11.1. COMPANY OVERVIEW 311
12.11.2. REVENUE ANALYSIS 311
12.11.3. PRODUCT PORTFOLIO 312
12.11.4. RECENT DEVELOPMENTS 312
12.12. GE HEALTHCARE 313
12.12.1. COMPANY OVERVIEW 313
12.12.2. REVENUE ANALYSIS 313
12.12.3. PRODUCT PORTFOLIO 314
12.12.4. RECENT DEVELOPMENTS 314
12.13. MEDITAS 315
12.13.1. COMPANY OVERVIEW 315
12.13.2. COMPANY SNAPSHOT 315
12.13.3. PRODUCT PORTFOLIO 315
12.13.4. RECENT DEVELOPMENTS 315
12.14. MEDTRONIC 317
12.14.1. COMPANY OVERVIEW 317
12.14.2. REVENUE ANALYSIS 317
12.14.3. PRODUCT PORTFOLIO 318
12.14.4. RECENT DEVELOPMENTS 318
12.15. ACCUMED CORP. 319
12.15.1. COMPANY OVERVIEW 319
12.15.2. COMPANY SNAPSHOT 319
12.15.3. PRODUCT PORTFOLIO 319
12.15.4. RECENT DEVELOPMENTS 319
12.16. IMTHERA MEDICAL 320
12.16.1. COMPANY OVERVIEW 320
12.16.2. COMPANY SNAPSHOT 320
12.16.3. PRODUCT PORTFOLIO 320
12.16.4. RECENT DEVELOPMENTS 320
13. RELATED REPORTS 248

Figures List
Figure 1 Europe Anti-Snoring Devices And Snoring Surgery Market: Segmentation 28
Figure 2 Europe Anti-Snoring Devices And Snoring Surgery Market: Geograhic Scope 29
Figure 3 Europe Anti-Snoring Devices And Snoring Surgery Market:
Data Triangulation 31
Figure 4 Europe Anti-Snoring Devices And Snoring Surgery Market: Snapshot (2016) 32
Figure 5 Europe Anti-Snoring Devices And Snoring Surgery Market:
Bottom Up Approach 33
Figure 6 Europe Anti-Snoring Devices And Snoring Surgery Market:
Top Down Approach 33
Figure 7 Europe Anti-Snoring Devices And Snoring Surgery Market: Interviews
By Region And Designation 34
Figure 8 Drivers, Restraints, Opportunities, And Challenges Of Europe Anti-Snoring Devices And Snoring Surgery Market 37
Figure 9 Europe Anti-Snoring Devices And Snoring Surgery Market: Segmentation 45
Figure 11 Rise In The Geriatric As Well As Obese Population And Technological Advancement In Anti-Snoring Devices Is Expected To Drive The Market For Anti-Snoring Devices And Snoring Surgery In The Forecast Period 2017 To 2024 46
Figure 12 Oral Appliances/Mouthpieces Segment Is Expected To Account For The Largest Share Of The Europe Anti-Snoring Devices And Snoring Surgery
Market In 2024 47
Figure 26 Europe Anti-Snoring Devices And Snoring Surgery Market: Snapshot (2016) 130
Figure 27 Europe Anti-Snoring Devices And Snoring Surgery Market:
By Country (2016) 131
Figure 28 Europe Anti-Snoring Devices And Snoring Surgery Market:
By Country (2017) 132
Figure 29 Europe Anti-Snoring Devices And Snoring Surgery Market:
By Country (2016 & 2024) 133
Figure 30 Europe Anti-Snoring Devices And Snoring Surgery Market,
By Product Type (2017 & 2024) 134


【レポートのキーワード】

いびき防止装置・いびき手術

★調査レポート[いびき防止装置・いびき手術のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2024年)] (コード:DBMR810026)販売に関する免責事項を必ずご確認ください。
★調査レポート[いびき防止装置・いびき手術のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2024年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆